European Embalming Products Company Limited 06909086 false 2022-12-01 2023-11-30 2023-11-30 The principal activity of the company is that of the sale of embalming products. Digita Accounts Production Advanced 6.30.9574.0 true false 06909086 2022-12-01 2023-11-30 06909086 2023-11-30 06909086 core:CurrentFinancialInstruments 2023-11-30 06909086 core:CurrentFinancialInstruments core:WithinOneYear 2023-11-30 06909086 core:AdditionsToInvestments 2023-11-30 06909086 core:PlantMachinery 2023-11-30 06909086 core:AllSubsidiaries 2023-11-30 06909086 bus:SmallEntities 2022-12-01 2023-11-30 06909086 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 06909086 bus:FullAccounts 2022-12-01 2023-11-30 06909086 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 06909086 bus:RegisteredOffice 2022-12-01 2023-11-30 06909086 bus:CompanySecretaryDirector1 2022-12-01 2023-11-30 06909086 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 06909086 core:PlantMachinery 2022-12-01 2023-11-30 06909086 countries:EnglandWales 2022-12-01 2023-11-30 06909086 2022-11-30 06909086 core:PlantMachinery 2022-11-30 06909086 2022-04-01 2022-11-30 06909086 2022-11-30 06909086 core:CurrentFinancialInstruments 2022-11-30 06909086 core:CurrentFinancialInstruments core:WithinOneYear 2022-11-30 06909086 core:PlantMachinery 2022-11-30 06909086 core:AllSubsidiaries 2022-11-30 iso4217:GBP xbrli:pure

Registration number: 06909086

European Embalming Products Company Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 November 2023

 

European Embalming Products Company Limited

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

3 to 8

 

European Embalming Products Company Limited

(Registration number: 06909086)
Balance Sheet as at 30 November 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

47,151

53,557

Investments

5

25,695

25,695

 

72,846

79,252

Current assets

 

Stocks

6

214,068

105,559

Debtors

7

180,312

169,695

Cash at bank and in hand

 

120,125

137,644

 

514,505

412,898

Creditors: Amounts falling due within one year

8

(115,806)

(76,322)

Net current assets

 

398,699

336,576

Total assets less current liabilities

 

471,545

415,828

Provisions for liabilities

(11,788)

(13,390)

Net assets

 

459,757

402,438

Capital and reserves

 

Called up share capital

100

100

Retained earnings

459,657

402,338

Shareholders' funds

 

459,757

402,438

 

European Embalming Products Company Limited

(Registration number: 06909086)
Balance Sheet as at 30 November 2023

For the financial year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 28 March 2024 and signed on its behalf by:
 

.........................................
Mrs P Y Y Dubresson
Company secretary and director

 

European Embalming Products Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of embalming services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax payable and deferred tax.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

European Embalming Products Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

25% on reducing balance

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for embalming services performed in the ordinary course of business.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

European Embalming Products Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 5 (2022 - 6).

 

European Embalming Products Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

4

Tangible assets

Plant and machinery
£

Total
£

Cost or valuation

At 1 December 2022

161,145

161,145

Additions

7,679

7,679

At 30 November 2023

168,824

168,824

Depreciation

At 1 December 2022

107,589

107,589

Charge for the year

14,084

14,084

At 30 November 2023

121,673

121,673

Carrying amount

At 30 November 2023

47,151

47,151

At 30 November 2022

53,557

53,557

5

Investments

2023
£

2022
£

Investments in subsidiaries

25,695

25,695

Subsidiaries

£

Cost or valuation

Additions

25,695

Provision

Carrying amount

At 30 November 2023

25,695

At 30 November 2022

25,695

 

European Embalming Products Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

6

Stocks

2023
£

2022
£

Other inventories

214,068

105,559

7

Debtors

Current

2023
£

2022
£

Trade debtors

158,613

128,194

Other debtors

21,699

41,501

 

180,312

169,695

 

European Embalming Products Company Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

8

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Trade creditors

54,913

11,376

Taxation and social security

31,375

15,192

Other creditors

29,518

49,754

115,806

76,322

9

Related party transactions

Summary of transactions with other related parties

During the year the directors had a loan account with the company. At the year end date, the amount owed to the directors was £25,376 (2023: £42,169).

Income and receivables from related parties

2023

Subsidiary
£

Amounts receivable from related party

146,366

2022

Subsidiary
£

Amounts receivable from related party

113,464